LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Convenience Stores & Lotto Businesses For Sale
Miscellaneous Businesses for Sale
Grocery Stores & Delis for Sale
Banquet Halls & Catering Businesses for Sale
Retirement Homes for Sale
Cleaning & Janitorial Businesses for Sale
Digital Marketing Business for Sale
Home Based Business Opportunities
Construction & Landscaping Businesses for Sale
Entertainment & Recreation Businesses for Sale
Healthcare & Medical Franchise Opportunities
Restaurant Franchises for Sale
Printing, Signs & Publishing Franchise Opportunities
Liquor Franchises for Sale
Senior Care Franchise for Sale
Bars & Pubs Franchises for Sale
Technology Franchise Opportunities
Home Based Franchise Opportunities
Consultancy & Training Franchise Opportunities
Finance & Accounting Franchise Opportunities
Industrial Buildings for Sale or Lease
Office Spaces for Sale or Rent
Land & Developments for Sale
Apartment Buildings for Sale
Industrial Units for Sale or Rent
Commercial Spaces for Sale or Lease
Miscellaneous Properties for Sale or Lease
Retail Spaces for Lease or Sale
Medical Buildings for Sale or Lease
Office Buildings for Sale or Rent
An email will be sent to registered email address.
Please select if you are: